|
1
|
Richter Z, Janszky J, Sétáló G Jr, Horváth
R, Horváth Z, Dóczi T, Seress L and Ábrahám H: Characterization of
neurons in the cortical white matter in human temporal lobe
epilepsy. Neuroscience. 333:140–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Santini E and Klann E: Genetically
dissecting cortical neurons involved in epilepsy in angelman
syndrome. Neuron. 90:1–3. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharop BR, Boldyriev OI, Batiuk MY,
Shtefan NL and Shuba YM: Compensatory reduction of Cav3.1
expression in thalamocortical neurons of juvenile rats of WAG/Rij
model of absence epilepsy. Epilepsy Res. 119:10–12. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Woodbury DM: Neurotransmitters and
epilepsy: Distinguishing characteristics and unifying precepts. Fed
Proc. 43:2529–2531. 1984.PubMed/NCBI
|
|
5
|
Werner FM and Coveñas R: Classical
neurotransmitters and neuropeptides involved in generalized
epilepsy in a multi-neurotransmitter system: How to improve the
antiepileptic effect? Epilepsy Behav. 71:124–129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ievglevskyi O, Isaev D, Netsyk O, Romanov
A, Fedoriuk M, Maximyuk O, Isaeva E, Akaike N and Krishtal O:
Acid-sensing ion channels regulate spontaneous inhibitory activity
in the hippocampus: Possible implications for epilepsy. Philos
Trans R Soc Lond B Biol Sci. 371:pii: 201504312016. View Article : Google Scholar
|
|
7
|
Lerche H, Shah M, Beck H, Noebels J,
Johnston D and Vincent A: Ion channels in genetic and acquired
forms of epilepsy. J Physiol. 591:753–764. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heuser K, Szokol K and Tauboll E: The role
of glial cells in epilepsy. Tidsskr Nor Laegeforen. 134:37–41.
2014.(In English; Norwegian). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Afawi Z, Oliver KL, Kivity S, Mazarib A,
Blatt I, Neufeld MY, Helbig KL, Goldberg-Stern H, Misk AJ,
Straussberg R, et al: Multiplex families with epilepsy: Success of
clinical and molecular genetic characterization. Neurology.
86:713–722. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vezzani A, Lang B and Aronica E: Immunity
and Inflammation in Epilepsy. Cold Spring Harb Perspect Med.
6:a0226992015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim DW, Sunwoo JS and Lee SK: Incidence
and localizing value of vertigo and dizziness in patients with
epilepsy: Video-EEG monitoring study. Epilepsy Res. 126:102–105.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim H, Thurman DJ, Durgin T, Faught E and
Helmers S: Estimating epilepsy incidence and prevalence in the US
pediatric population using nationwide health insurance claims data.
J Child Neurol. 31:743–749. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang S, Zhang J, Zhang S and Fu X:
Epilepsy in adults with supratentorial glioblastoma: Incidence and
influence factors and prophylaxis in 184 patients. PLoS One.
11:e01582062016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Loewen JL, Barker-Haliski ML, Dahle EJ,
White HS and Wilcox KS: Neuronal injury, gliosis, and glial
proliferation in two models of temporal lobe epilepsy. J
Neuropathol Exp Neurol. 75:366–378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eid T, Lee TW, Patrylo P and Zaveri HP:
Astrocytes and glutamine synthetase in epileptogenesis. J Neurosci
Res. Jul 18–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamilton NB and Attwell D: Do astrocytes
really exocytose neurotransmitters? Nat Rev Neurosci. 11:227–238.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
James LR, Andrews S, Walker S, de Sousa
PR, Ray A, Russell NA and Bellamy TC: High-throughput analysis of
calcium signalling kinetics in astrocytes stimulated with different
neurotransmitters. PLoS One. 6:e268892011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Magistretti PJ, Sorg O, Yu N, Martin JL
and Pellerin L: Neurotransmitters regulate energy metabolism in
astrocytes: Implications for the metabolic trafficking between
neural cells. Dev Neurosci. 15:306–312. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sukigara S, Dai H, Nabatame S, Otsuki T,
Hanai S, Honda R, Saito T, Nakagawa E, Kaido T, Sato N, et al:
Expression of astrocyte-related receptors in cortical dysplasia
with intractable epilepsy. J Neuropathol Exp Neurol. 73:798–806.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carmignoto G and Haydon PG: Astrocyte
calcium signaling and epilepsy. Glia. 60:1227–1233. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mecha M, Carrillo-Salinas FJ, Feliú A,
Mestre L and Guaza C: Microglia activation states and cannabinoid
system: Therapeutic implications. Pharmacol Ther. 166:40–55. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ni R, Mu L and Ametamey S: Positron
emission tomography of type 2 cannabinoid receptors for detecting
inflammation in thecentral nervous system. Acta Pharmacol Sin. Jun
19–2018.(Epub ahead of print). View Article : Google Scholar
|
|
23
|
Rizzo V, Carletti F, Gambino G, Schiera G,
Cannizzaro C, Ferraro G and Sardo P: Role of CB2 receptors and cGMP
pathway on the cannabinoid-dependent antiepileptic effects in an in
vivo model of partial epilepsy. Epilepsy Res. 108:1711–1718. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hocker SE: Status epilepticus. Continuum
(Minneap Minn) 21 (5 Neurocritical Care). 1–1383. 2015.
|
|
25
|
Xu J: New insights into GFAP negative
astrocytes in calbindin D28k immunoreactive astrocytes. Brain Sci.
8(pii): E1432018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu JJ, Diaz P, Bie B, Astruc-Diaz F, Wu J,
Yang H, Brown DL and Naguib M: Spinal gene expression profiling and
pathways analysis of a CB2 agonist (MDA7)-targeted prevention of
paclitaxel-induced neuropathy. Neuroscience. 260:185–194. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Molina-Holgado E, Vela JM, Arévalo-Martín
A, Almazán G, Molina-Holgado F, Borrell J and Guaza C: Cannabinoids
promote oligodendrocyte progenitor survival: Involvement of
cannabinoid receptors and phosphatidylinositol-3 kinase/Akt
signaling. J Neurosci. 22:9742–9753. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim J and Li Y: Chronic activation of CB2
cannabinoid receptors in the hippocampus increases excitatory
synaptic transmission. J Physiol. 593:871–886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Devane WA, Dysarz FA III, Johnson MR,
Melvin LS and Howlett AC: Determination and characterization of
cannabinoid receptor in rat brain. Mol Pharmacol. 34:605–613.
1988.PubMed/NCBI
|
|
30
|
Jing N, Fang B, Wang ZL and Ma H: Remote
ischemia preconditioning attenuates blood-spinal cord barrier
breakdown in rats undergoing spinal cord ischemia reperfusion
injury: Associated with activation and upregulation of CB1 and CB2
receptors. Cell Physiol Biochem. 43:2516–2524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seifert G and Steinhäuser C:
Neuron-astrocyte signaling and epilepsy. Exp Neurol. 244:4–10.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Viscomi MT, Oddi S, Latini L, Pasquariello
N, Florenzano F, Bernardi G, Molinari M and Maccarrone M: Selective
CB2 receptor agonism protects central neurons from remote
axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci.
29:4564–4570. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duan W, Chen Y and Wang XR: MicroRNA-155
contributes to the occurrence of epilepsy through the PI3K/Akt/mTOR
signaling pathway. Int J Mol Med. 42:1577–1584. 2018.PubMed/NCBI
|
|
34
|
Khwanraj K, Madlah S, Grataitong K and
Dharmasaroja P: Comparative mRNA expression of eEF1A isoforms and a
PI3K/Akt/mTOR pathway in a cellular model of parkinson's disease.
Parkinsons Dis. 2016:87160162016.PubMed/NCBI
|
|
35
|
Zhang W, Liu J, Hu X, Li P, Leak RK, Gao Y
and Chen J: n-3 polyunsaturated fatty acids reduce neonatal
hypoxic/ischemic brain injury by promoting phosphatidylserine
formation and Akt signaling. Stroke. 46:2943–2950. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Roy A, Skibo J, Kalume F, Ni J, Rankin S,
Lu Y, Dobyns WB, Mills GB, Zhao JJ, Baker SJ and Millen KJ: Mouse
models of human PIK3CA-related brain overgrowth have acutely
treatable epilepsy. Elife. 4:pii: e127032015. View Article : Google Scholar
|
|
37
|
Hester MS, Hosford BE, Santos VR, Singh
SP, Rolle IJ, LaSarge CL, Liska JP, Garcia-Cairasco N and Danzer
SC: Impact of rapamycin on status epilepticus induced hippocampal
pathology and weight gain. Exp Neurol. 280:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lasarge CL and Danzer SC: Mechanisms
regulating neuronal excitability and seizure development following
mTOR pathway hyperactivation. Front Mol Neurosci. 7:182014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bateup HS, Denefrio CL, Johnson CA,
Saulnier JL and Sabatini BL: Temporal dynamics of a homeostatic
pathway controlling neural network activity. Front Mol Neurosci.
6:282013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Berdichevsky Y, Dryer AM, Saponjian Y,
Mahoney MM, Pimentel CA, Lucini CA, Usenovic M and Staley KJ:
PI3K-Akt signaling activates mTOR-mediated epileptogenesis in
organotypic hippocampal culture model of post-traumatic epilepsy. J
Neurosci. 33:9056–9067. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Groszer M, Erickson R, Scripture-Adams DD,
Lesche R, Trumpp A, Zack JA, Kornblum HI, Liu X and Wu H: Negative
regulation of neural stem/progenitor cell proliferation by the Pten
tumor suppressor gene in vivo. Science. 294:2186–2189. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Su CH, Lan KH, Li CP, Chao Y, Lin HC, Lee
SD and Lee WP: Phosphorylation accelerates geldanamycin-induced Akt
degradation. Arch Biochem Biophys. 536:6–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liao Y and Hung MC: Physiological
regulation of Akt activity and stability. Am J Transl Res. 2:19–42.
2010.PubMed/NCBI
|
